Amanda Megan Marcotulli, PA-C

Amanda Marcotulli practices at The University of Texas MD Anderson Cancer Center in Houston, Texas, part of The University of Texas System.

Amanda Marcotulli's NPI, 1245408582, was assigned on February 20, 2008. Amanda Marcotulli holds Texas license PA05687.

Amanda Marcotulli's primary practice is The University of Texas MD Anderson Cancer Center, at 1515 Holcombe Blvd, Houston, TX 77030.

Amanda Marcotulli's primary practice is The University of Texas MD Anderson Cancer Center in Houston, Texas, part of The University of Texas System. The medical group on file is Physicians Referral Service.

Dmand AI tracks the electronic health record (EHR) system at each site where Amanda Marcotulli practices. Vendor and product names are available with a free account.

Physician assistant is Amanda Marcotulli's primary specialty in the NPI Registry, under taxonomy code 363A00000X. Amanda Marcotulli is licensed in Texas.

CMS data shows 26 Medicare services from Amanda Marcotulli across 1 procedure code in 2024, for 37 Medicare patients. Medicare paid $1,089 for them. Every service was in a facility, such as a hospital, rather than an office.

CMS counts 37 Medicare patients who saw Amanda Marcotulli in 2024. The largest group is 65 to 74, with 20 patients. 75% of them have high blood pressure, and 68% have high cholesterol. Their average risk score is 4.53, where 1.00 is the Medicare average, so they are sicker than most Medicare patients.

Across all payers, Dmand AI patient panel data puts Amanda Marcotulli's median patient age at 69, with 39% women.

In 2024, Amanda Marcotulli wrote 670 Medicare Part D claims for 85 patients. 85% of them were for generic drugs. CMS names the drug for 448 of them, across 15 drugs with 11 or more claims each, at $509,305 in total drug cost.

CMS publishes a Merit-based Incentive Payment System (MIPS) score of 84 out of 100 for Amanda Marcotulli for performance year 2024, reported as part of a group. Amanda Marcotulli accepts Medicare assignment, so Medicare's approved amount is taken as full payment.

CMS Open Payments shows 9 general payments to Amanda Marcotulli from 5 drug and device companies from 2024 to 2025. Food and beverage make up the largest share, 88% of the total. Sobi, Inc paid the most, $202.